Fluicell Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Joakim Wahlberg, was filed 16 Mar 2026.
Fluicell: what insiders have been doing
This page follows insider dealings at Fluicell as filed with Finansinspektionen. 1 insider has disclosed 5 filings since 23 October 2025.
Not one open-market sale was filed. On the buying side, 1 insider reported 5 purchases totalling €2,188. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 finance chief. At €981, the purchase published on 18 January 2026 by Joakim Wahlberg is the largest of the period.
For context, the typical company on the same exchange (median of 1,027 companies) published 9 filings over the same period, against 5 filings here. Since 2018, the database holds 80 purchases and 38 sales by insiders of the company.
The last insider purchase was made public on 16 March 2026, 237 days ago. Filings reach the Finansinspektionen feed a median of 4 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -66.7%Entry 1,748.53 · Close at T+365 582.12
- -40.0%Entry 1,755.82 · Close at T+365 1,053.49
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
- 204 shares@ SEK 11.001.5% of flowAktieISIN SE0023595459FI:csv-c00263a70e928ee14f9bCanonical exit: 11 Jun 2026 (T+90)
- 39 shares@ SEK 10.90510.3% of flowAktieISIN SE0023595459FI:csv-600179e9df73b8617c5aCanonical exit: 3 Jun 2026 (T+90)
- 1,000 shares@ SEK 10.206.8% of flowAktieISIN SE0010831321FI:csv-1e8ca1fe7f533f980a63Canonical exit: 19 Apr 2026 (T+90)
- 7 shares@ SEK 10.200.0% of flowAktieISIN SE0023595459FI:csv-a12198160f3f1a7890caCanonical exit: 12 Apr 2026 (T+90)
- 1,000 shares@ SEK 10.507.0% of flowAktieISIN SE0010831321FI:csv-ca126fb3d3e9885c2afdCanonical exit: 13 Apr 2026 (T+90)
- 3,000 shares@ SEK 10.33324.2% of flowAktieISIN SE0023595459FI:csv-4678e0e57e5e43c9ca25Canonical exit: 14 Aug 2025 (T+90)
- 300 shares@ SEK 10.0252.3% of flowAktieISIN SE0023595459FI:csv-1f2542fbe7596642aa62Canonical exit: 14 Aug 2025 (T+90)
- 700 shares@ SEK 10.3265.6% of flowAktieISIN SE0023595459FI:csv-02441f327a1a81515ff2Canonical exit: 14 Aug 2025 (T+90)
- 200,000 shares@ SEK 0.0813.0% of flowAktieISIN SE0010831321FI:csv-1f75d79988c5ed0f4857
- 200,000 shares0TeckningsoptionISIN SE0021151073FI:csv-d7b268fa0eeee658b9f9
- 386,365 shares0TeckningsoptionISIN SE0021151073FI:csv-429895829d01f0a48316
- 386,365 shares@ SEK 0.0825.1% of flowTeckningsoptionISIN SE0021151073FI:csv-adddf4858b85ea6e5de5
- 204,550 shares@ SEK 0.08100.0% of flowAktieISIN SE0010831321FI:csv-4c19d0c684e6a525b8be
- 204,550 shares0TeckningsoptionISIN SE0021151073FI:csv-ae1a4887a8248df05a34
- 305,000 shares@ SEK 0.083.5% of flowAktieISIN SE0010831321FI:csv-1b6eaddc9dade0c4429e
- 175,000 shares@ SEK 0.082.0% of flowAktieISIN SE0010831321FI:csv-4f5a8f06514ddca809a7
- 305,000 shares0WarrantISIN SE0021151073FI:csv-8ded4d30021e8da97603
- 175,000 shares0WarrantISIN SE0021151073FI:csv-64c250800e40250f085f
- 190,000 shares@ SEK 0.082.2% of flowAktieISIN SE0010831321FI:csv-3483dc32b31f30ce0281
- 190,000 shares0WarrantISIN SE0021151073FI:csv-5a09abfb4bfc25512845
- 477,275 shares@ SEK 0.08100.0% of flowAktieISIN SE0010831321FI:csv-28657c03fc402bfc1f73
- 477,275 shares0TeckningsoptionISIN SE0021151073FI:csv-09b36df0e89b00156970
- 227,000 shares@ SEK 0.0811.7% of flowAktieISIN SE0010831321FI:csv-acf80571b05a486e6dff
- 227,000 shares0WarrantISIN SE0021151073FI:csv-b91912638b2e610d2ffb
- 250,000 shares@ SEK 0.0826.4% of flowAktieISIN SE0010831321FI:csv-6ddee641bcf2ddeda3ea
25 of 156 declarations
About Fluicell
Fluicell is a company specializing in the development of microfluidic technologies for research in biology and medicine. It offers innovative solutions for cellular analysis and the manipulation of individual cells.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations